<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02694406</url>
  </required_header>
  <id_info>
    <org_study_id>MRI-CAM</org_study_id>
    <nct_id>NCT02694406</nct_id>
  </id_info>
  <brief_title>MRI Perfusion in Adnexal Masses</brief_title>
  <acronym>MRI-CAM</acronym>
  <official_title>Added Value of MRI Perfusion in Evaluation of Complex Adnexal Masses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      As ovarian cancer is characterized by an anarchic neovascularization resulting in a wide
      number of immature microvessels. These vessels are characterized by a lack of coverage by
      pericytes and the higher expression of one of the receptors of Vascular Endothelial Growth
      Factor on both endothelial and epithelial cells of ovarian cystadenocarcinomas. These physio
      pathogenic characteristics have been demonstrated to be in line with variations of MR
      perfusion parameters.

      Unlike many lesions that occur in other parts of the body, biopsy should not be performed in
      adnexal masses that demonstrate no evidence of peritoneal disease because it may cause
      spillage of cystic contents, potentially leading to iatrogenic up-staging of what may have
      been a malignant tumor that was limited.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Actual">December 1, 2017</completion_date>
  <primary_completion_date type="Actual">November 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>detect the number of malignant adnexal masses</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Complex Adnexal Masses</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI perfusion</intervention_name>
    <description>contrast-enhanced MR imaging including perfusion weighted imaging (PWI)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with adenxal masses
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  complex adnexal mass

          -  patient fit for surgery

        Exclusion Criteria:

          -  any general contraindication to MRI

          -  severely ill patients

          -  those with claustrophobia.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ahmed Abbas</name>
      <address>
        <city>Assiut</city>
        <state>Cairo</state>
        <zip>002</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ahmed Abbas</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>February 24, 2016</study_first_submitted>
  <study_first_submitted_qc>February 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2016</study_first_posted>
  <last_update_submitted>June 26, 2018</last_update_submitted>
  <last_update_submitted_qc>June 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Abbas</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Diagnosis</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

